Detalhe da pesquisa
1.
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
N Engl J Med
; 373(14): 1318-28, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26422722
2.
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.
Dermatol Ther
; 31(1)2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29215183
3.
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.
Lancet
; 386(9993): 552-61, 2015 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26051365
4.
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.
Dermatology
; 232(2): 230-6, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26678060
5.
Rhodamine intense pulsed light versus conventional intense pulsed light for facial telangiectasias.
J Cosmet Laser Ther
; 18(2): 80-5, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26736070
6.
Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab.
J Drugs Dermatol
; 15(2): 134-8, 2016 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26885779
7.
Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet
; 384(9959): 2036-45, 2014 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25127208
8.
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1).
J Am Acad Dermatol
; 73(1): 37-49, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26089047
9.
Chronically sun-damaged melanomas express low levels of nuclear glutathione-S-transferase-π: an epidemiological and clinicopathological study in Italy.
Acta Derm Venereol
; 95(1): 40-4, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24535144
10.
Thymic stromal lymphopoietin links keratinocytes and dendritic cell-derived IL-23 in patients with psoriasis.
J Allergy Clin Immunol
; 134(2): 373-81, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24910175
11.
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry.
J Am Acad Dermatol
; 70(2): 257-62.e3, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24355410
12.
What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practice.
Dermatology
; 229(4): 324-32, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25402662
13.
Randomized, within-patient, clinical trial comparing fluorine-synthetic fiber socks with standard cotton socks in improving plantar pustulosis.
Dermatology
; 228(2): 166-71, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24434748
14.
Dermoscopy as an adjuvant tool for detecting skin leiomyomas in patient with uterine fibroids and cerebral cavernomas.
BMC Dermatol
; 14: 7, 2014 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24739762
15.
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas.
Proc Natl Acad Sci U S A
; 108(33): 13710-5, 2011 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21807998
16.
Clinical markers predictive of primary inefficacy: a "real life" retrospective study in psoriatic patients treated with etanercept.
Drug Dev Res
; 75 Suppl 1: S27-30, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381970
17.
Treatment adherence to different etanercept regimens, continuous vs. intermittent, in patients affected by plaque-type psoriasis.
Drug Dev Res
; 75 Suppl 1: S31-4, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381971
18.
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations.
Drug Dev Res
; 75 Suppl 1: S11-4, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25381966
19.
Frequency of melanocytic nevi in psoriatic patients is related to treatment and not to disease severity.
J Am Acad Dermatol
; 69(6): 947-53, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24094540
20.
IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
J Immunol
; 186(9): 5435-42, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21441456